Diagnostics and Tools Update:EXAS,GNMK,QGEN, RGDX
Busy Day Today -Overall a Lot of Green Screen The diagnostics and tools sector has seen resilience over the past 30 days as the market corrected 7% or more.Bellwether large cap tools stocks with revenue growth such as ILMN,NEOG, TMO have held up well helped by M&A action and good...
Flight to Safety with Greek Crisis: Some Biotech Winners-SQNM,REGN
Europe debt woes, riots in Greece and a 3% CPI increase for a 12 month period spooked investors. All sectors sold off today with major indices down: NASDAQ off 1.77%,Dow off 1.5%,S&P off 1.7%. Energy, materials, technology and financials were weakest, and all down YTD. The QQQ was down 1.9%...
Relief Rally Boosts Biotechs: BIIB,EXEL,REGN
The market rallied today with the NASDAQ up 1.48 % and the S&P up 1.26%. The leading sectors today were capital goods , materials and energy. Biotechs overall were up only 0.8% but were much better even though our mid-cap index was up only 0.49%. Within the Rayno Life Science Portfolio big...
Post-ASCO Scoreboard Part 2
Following up on the previous post we can review selected small and mid-stocks participating in the ASCO Conference look at performance over 3 months from March 14 to June 13 including a 7% correction in the market overall. Most biotech stocks peaked in Q2 2011. See previous post for ASCO news...
ASCO Winners Part 1: ARIA,ECYT,INCY
Despite an ASCO “sell on the news” and a severe Q2 correction some mid and small cap cancer related stocks are still up although off their highs. See commentary and news from earlier posts. More on these and others...
